NL-OMON50430
Recruiting
Phase 3
Intralesional steroid injections to prevent refractory strictures in patients with esophageal atresia - a randomized controlled trial - STEPS-EA trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- narrowing esophagus
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Children with EA type C who underwent primary anastomotic surgery
- •\- Age \>\=3 months at the time of the 3rd dilatation
- •\- In need of a 3rd dilatation
- •\- Written informed consent by both parents or guardians if applicable
Exclusion Criteria
- •\- Age \<3 months
- •\- Known inability from previous dilatations to use an endoscope with a size of
- •\- No parental written informed consen
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Prevention of recurrent narrowing of the esophagus after correction of esophageal atresia by injecting steroidsEUCTR2018-002863-24-NLErasmus MC110
Active, not recruiting
Phase 1
Prevention of recurrent narrowing of the esophagus after correction of esophageal atresia by injecting steroidsRecurrent stenosis after correction of esophageal atresiaMedDRA version: 20.0Level: LLTClassification code 10045322Term: Ulcer of eosophagusSystem Organ Class: 100000004856Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]EUCTR2018-002863-24-DKErasmus MC110
Active, not recruiting
Phase 1
Is intralesional steroid injection effective in treating recurrent stricture following reconstruction of esophageal malformation in children?Recurrent anastomotic strictures in the esophagus following surgical repair with primary anastomosis of esophageal atresia in neonates.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]EUCTR2022-003287-25-SEErasmus University Medical Center - Sophia Childrens Hospital110
Active, not recruiting
Phase 1
Prevention of recurrent narrowing of the esophagus after correction of esophageal atresia by injecting steroidsRecurrent stenosis after correction of esophageal atresiaTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]EUCTR2018-002863-24-FIErasmus MC110
Active, not recruiting
Phase 1
Intralesional steroids injections to prevent refractory strictures in patients with esophageal atresia - a randomized controlled tiralrefractory strictures in patients with esophageal atresiaMedDRA version: 20.0Level: PTClassification code 10021530Term: Imperforate oesophagusSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]EUCTR2018-002863-24-FRErasmus Universitu Medical Center - Sophia Children's Hospital110